Exclusive: David Liu startup to focus on CRISPR delivery; Medicare wants to increase payments for heart rehab

Taking stock of the drug industry, from the lab to the medicine chest

September 18, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

STAT STAT+ | David Liu startup to focus on getting CRISPR therapy to hard-to-reach cells Nvelop, already backed by $100 million, is the latest entry in a race among top labs to solve a gene cargo-delivery problem. By Jason Mast STAT+ | Medicare wants to increase payments for heart rehab. Hospitals see an opening to get more But hospitals want Medicare to make retroactive add-on payments, and are pressuring Medicare to kill all site-neutral proposals. By Bob Herman Opinion: Where are HHS and the FTC on online privacy for people with substance use disorder? The FTC has not yet addressed any of the thousands of apps providing services related to drug use, addiction, and recovery. By Jacqueline Seitz

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser